Wellington Partners Overview

Wellington Partners is a pan-European venture capital firm founded in 1998, focusing on early- and growth-stage life science companies across Europe and beyond. With offices in Munich, London, and Zurich, the firm has raised over €590 million for life science funds and has achieved 27 life science exits, IPOs, and trade sales. Their investment scope includes therapeutics, medical devices, diagnostics, digital health, and industrial biotechnology. Wellington Partners typically leads or co-leads financing rounds ranging from €0.5 million to €20 million, with their own commitment going as high as €15 million, depending on the company's maturity. They provide not only financial resources but also strategic support, leveraging their global scientific and commercial network to assist portfolio companies in areas such as preclinical and clinical development, regulatory approval processes, and market entry into key healthcare markets in Europe, the U.S., and Asia.

Is Wellington Partners the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Wellington Partners, along with a list of other relevant VCs, is available on Hopohopo.io.